Replies to post #167998 on Biotech Values

[DewDiligence]

Crazy that ACHN and ENTA have somewhat of comparable market caps. That shouldn't be imo.

Well, you’ve seen the quote at the bottom of my iHub messages :- ) You’ve taken action and now you have to be patient and let the story play out. For near-term news flow, there are two opportunities: i) ABBV reveals SAPHIRE-1/2 topline data in conjunction with its 3Q13 earnings report and CC on 10/25/13; or ii) ABBV/ENTA issue a PR on SAPHIRE/1-2 topline data to coincide with the start of AASLD on 11/1/13.